品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

Iwai-Chem/iMatrix-411 (Size 1050ug)/Cell Culture/N-892042

价格
¥23200.00
货号:N-892042
浏览量:127
品牌:Iwai-Chem
服务
全国联保
正品保证
正规发票
签订合同
商品描述

iMatrix-411

Laminin-411 E8 fragment protein is known to bind to Intergin α6β1 and α71β1 of the cell surface, making an ideal cell culture matrix.

iMatrix-411 is highly purified human Laminin 411-E8 fragments recombinantly expressed by CHO-S cell.

Product Size : 1050ug  (175ug x 6 pcs.)

<Application>

iMatrix-411 can be used as cell culture matrix for various cell types including ES/iPS cells.

<Contents>

Liquid Solution (175ug/vial @0.5mg/mL) Solvent: PBS(-)) 

**Specification **
Format: Solution (175ug/vial @0.5mg/mL) 
Storage temperature: 2-15°C

------------------------------------------------------------------------------------------------
****When culturing ES/iPS cell, Feeder Free and Single cell subculture can be done using iMatrix-411.*****

*License to manufacture and sell this product has been obtained from Osaka University & Kyoto University.*

___________________________________________________________________________________________________

[Reference Literature]
1. Takayama K et all., Laminin 411 and 511 promote the cholangiocyte differentiaion of human induced pluripotent stem cells. Biochemical and biophysical research communications, 474 (1), 91-96, 2016

2. Ohta R et al., Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells. Scientific Reports, 6(35680),1-12, 2016

 

FOR RESEARCH USE ONLY, NOT FOR USE IN DIAGNOSTIC PROCEDURES.

Manufactured by : Nippi, Inc.

Questions about this product? Ready to place an order? Email us at orders@iwai-chem.comor give us a call: (650) 486-1541

Iwai-Chem我们的合作伙伴公司Bio Matrix Research,Inc.(BMR)正在申请专利,CELIXSYS™是一种新颖的单克隆抗体筛选方法(免疫沉淀等效系统),可保持抗原构象完整且表位不受空间位阻。  通过克服传统的基于固相的筛选方法(例如抗原包被的ELISA,斑点印迹或蛋白质印迹)的缺点,CELIXSYS™使我们能够获得适用于各种应用的卓越单克隆抗体,例如高灵敏度夹心ELISA,免疫色谱法或抗体阵列系统,以及免疫沉淀和蛋白质印迹。CELIXSYS™使得开发有益的单克隆抗体成为可能,而迄今为止,传统方法尚无法实现。展望未来,这项新技术的应用领域将继续从基础研究和临床诊断试剂扩展到抗体药物的探索。